Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 332 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 
 

Table of Contents   
ORIGINAL ARTICLE  
Year : 2011  |  Volume : 22  |  Issue : 2  |  Page : 237-244
Entamoeba histolytica/Entamoeba dispar infection in chronic hemodialysis patients


1 Faculty of Medicine, Federal University of Uberlandia, Uberlandia, Brazil
2 Faculty of Biological Sciences, Federal University of Uberlandia, Uberlandia, Brazil
3 Clinical Research Unit/Nefroclínica, Uberlandia, Brazil

Click here for correspondence address and email

Date of Web Publication18-Mar-2011
 

   Abstract 

To determine the prevalence of Entamoeba histolytica/E. dispar (Eh/Ed) in chronic hemodialysis (HD) patients, we collected 330 samples of feces from 110 patients, and nine indivi­duals were found to be positive for Eh/Ed. We compared the infected patients with a group of 14 uninfected HD patients. Both groups were analyzed for their signs, symptoms and socio-economic characteristics using questionnaires. Blood tests were also performed in both the groups. Although both groups did not differ statistically with respect to their signs, symptoms and socio-economic conditions, there was a trend toward a greater number of individuals with diarrhea in the Eh/Ed infected group. In conclusion, we suggest that a parasitological examination of the patient's stool to detect the Eh/Ed complex should be included with the routine tests so that those patients with a positive fecal test could be initiated on appropriate anti-Eh/Ed therapy.

How to cite this article:
Ferreira-Filho SR, da Costa Braga FC, de Sa DM, Nunes EB, Parreira Soares JS, Padovese SM, de Oliveira AC, Ferreira Oliveira GM, dos Passos G, Lemes HP. Entamoeba histolytica/Entamoeba dispar infection in chronic hemodialysis patients. Saudi J Kidney Dis Transpl 2011;22:237-44

How to cite this URL:
Ferreira-Filho SR, da Costa Braga FC, de Sa DM, Nunes EB, Parreira Soares JS, Padovese SM, de Oliveira AC, Ferreira Oliveira GM, dos Passos G, Lemes HP. Entamoeba histolytica/Entamoeba dispar infection in chronic hemodialysis patients. Saudi J Kidney Dis Transpl [serial online] 2011 [cited 2020 Jun 6];22:237-44. Available from: http://www.sjkdt.org/text.asp?2011/22/2/237/77597

   Introduction Top


Patients with chronic renal failure (CRF) on dialysis treatment have a reduced immune res­ponse to various antigens, [1],[2],[3],[4],[5],[6],[7],[8],[9] such as inadequate response to vaccinations. [10],[11] Sepsis-related death is between 100 and 300-times more fre­quent in patients undergoing hemodialysis (HD) compared with the general population [12] of im­portant infections such as Mycobacterium tuberculosis[13] and hepatitis B and C viruses and the immunodeficiency virus (HIV). [14],[15],[16],[17],[18],[19] More­over, infectious diseases occupy the second leading cause of death in this population. [20]

There are little data concerning the contribu­tion of intestinal parasitic infections to protein calorie malnutrition and changes in the im­mune response. [21],[22],[23],[24] Entamoeba histolytica is in­volved in the formation of abscesses in diffe­rent body systems. [25],[26],[27],[28] The clinical manifes­tations of patients with E. histolytica infec­tions, without other associated comorbidities, are highly variable. Most of these infected pa­tients show no symptoms, while a small propor­tion of them manifest with diarrhea, fever and liver abscesses. [29]

Diagnosing E. histolytica infection solely through an optical microscope analysis of the patient's fresh feces is very difficult because of the similarity with the related species, E. dispar. While an invasive character is only as­signed to E. histolytica, there are no data demonstrating that E. dispar could promote health damage in humans. However, experimental studies have shown that an association with other pathogens was able to promote signi­ficant cellular damage. [30],[32],[33],[34] HD patients often have clinical complaints similar to individuals with amebiasis, especially with regard to the gastrointestinal symptoms, such as changes in the number of defecation and the consistency of the feces. [35]

We aim in this study to determine the clini­cal, laboratory and radiological findings in HD patients infected with the Eh/Ed complex in addition to the potential risk factors for ame­biasis and the prevalence of intestinal parasites in HD patients.


   Patients and Methods Top


After approval by the ethics committee of the Federal University of Uberlandia, 110 of the 175 patients with chronic renal failure on HD treatment in the Nefroclinica of Uberlandia, Minas Gerais between March 2005 and April 2007 were recruited into this study. Three stool samples were collected from each patient on different days, and a total of 330 samples were evaluated. All samples were examined by direct microscopy using the method of Hoff­man. [36] Patients whose fecal samples were po­sitive for Eh/Ed complex were subjected to clinical study and laboratory investigations, in­cluding abdominal ultrasound. They were com­pared with HD patients who were negative for both Eh/Ed on stool examination. The search for potential risk factors for an Eh/Ed infection was performed using a questionnaire developed specifically for this study.

The distinction between Eh and Ed by PCR was not one of the endpoints of this study.


   Statistical Analysis Top


The data were entered into the Epidata soft­ware. [37],[38] Data analyses were performed using the EpiInfo [39] and BioEstat softwares. [40] Statisti­cal analyses were conducted in accordance with the following steps. First, the distribution of the frequency of variables was collected for the study population and for the consistency of the data. Next, the distribution of the frequencies of all of the variables was calculated, charac­terizing the study population according to de­mographic and economic factors related to the participant's exposure. Univariate analysis for the household questionnaire was divided into two phases: (1) the demographic variables and the infrastructure of the home were assessed, and (2) the behavioral variables and hygiene were assessed. A univariate analysis was used to test the binomial to compare the two pro­portions (non-parametric test), and an odds ratio (OR) with a 95% confidence interval was used to quantify the association between the risk factors and the investigated Eh/Ed infection. Multivariate analysis was conducted using the logistic regression model in the following se­quence: the variables were selected from the univariate analysis, and all of those considered biologically important with respect to the Eh/ Ed infection (i.e., categorical variables) were transformed into dummy variables.


   Results Top


The study included 110 patients, consisting of 69 males and 41 females. The average age of the group was 52.1 ± 4.6 years, and the duration of hemodialysis treatment was 3.2 ± 1.6 years. Of the study subjects, 96 were re­sidents of Uberlandia and 14 were from neigh­boring towns. The initial results are shown in [Figure 1]. The Eh/Ed complex was the most co­mmon parasite observed during the examination of the subjects' fresh feces, corresponding to 8.2% (nine patients) of all the patients exa­mined. In both the study group and the con­trols, no patient presented with fever or hepa­tomegaly at the time of the study. Among the five patients in the Eh/Ed-positive group that were also surveyed for ultrasonography, none had a liver abscess, and among the 13 control subjects, none were found to have any signi­ficant liver changes. Only one patient in the Eh/Ed-positive group had eosinophilia, while five patients in the control group had eosino­philia. Anemia was identified in 85.7% of pa­tients in the Eh/ Ed-positive group and in 100% of the controls [Table 1]. In the univariate ana­lysis of the studied clinical variables, no varia­ble presented a significant difference between the Eh/Ed-positive group and the controls [Table 1]. The univariate analysis for the household questionnaire was divided into two phases. In the first phase, the demographic variables and infrastructure of the household were assessed [Table 2], and in the second phase, the beha­vioral and health variables were assessed [Table 3]. The investigated variables showed no sta­tistically significant differences between the Eh/Ed-positive group and the controls. The household survey showed that none of the investigated variables had a P <0.25 and, thus, it was not possible to construct a logistic re­gression model with potential clinical risk fac­tors for infection by Eh/Ed among the HD pa­tients. As none of the investigated variables were significantly changed (P < 0.05, 95% CI), it was not possible to construct a final multi­variate logistic model.
Figure 1: Distribution of intestinal parasites found in hemodialysis patients (n=110).

Click here to view
Table 1: Distribution of the cases and controls for Entamoeba histolytica/Entamoeba dispar with respect to the secondary clinical variables between patients undergoing hemodialysis.

Click here to view
Table 2: Distribution of the cases and the controls for Entamoeba histolytica/E. dispar for the secondary demographic variables and home infrastructures in hemodialysis patients.

Click here to view
Table 3: Entamoeba histolytica/E. dispar: Hygienic conditions among patients undergoing hemodialysis (positive cases versus controls).

Click here to view


Of the nine patients who formed the group of Eh/Ed-positive cases, one underwent a kidney transplant and two died of cardiovascular cau­ses during the study period; however, one of these patients had already responded to the questionnaires. Thus, the medical histories and interviews were conducted in seven of the pa­tients from the Eh/Ed-positive group. In the control group, one patient also died from car­diovascular causes and another changed to another form of dialysis; thus, leaving the study protocol. We inserted two new non-infected patients with similar characteristics to those who left the study, and then we conducted in­terviews with the 14 control patients, as re­quired. None of the three deaths from the Eh/ Ed-positive patient group were related to com­plications of the Eh/Ed infection.


   Discussion Top


Our data show that 8.2% of the population on hemodialysis was infected with the Eh/Ed complex. We did not observe any differential signs or clinical symptoms in the patients with and without the intestinal parasite. The social conditions in which the Eh/Ed-positive pa­tients lived were also not different from those presented by the control group. Accordingly, it is unlikely that the hygienic conditions of the positive patients were a factor in their infec­tion, as both studied groups of patients had good structures of water and sewage in their residence. During the study period, there were no significant differences in weight loss, epi­sodes of fever, vomiting and abdominal pain.

Despite the fact that the microscopic exami­nation of the fresh feces of patients - to search for cysts and/or trophozoites is considered the most common method for diagnosing intes­tinal amebiasis - this procedure is being re­assessed for its efficacy since the discovery of another non-pathogenic species of Entamoeba. A reclassification was made by Huston and Petri in 1999, when they defined Entamoeba histolytica as a pathogen and Entamoeba dis­par was defined as non-pathogenic and unable to cause disease to its host. [41] This reclassi­fication was based on the different aspects of clinical, biochemical, immunological and ge­netic characteristics found between these two protozoans. Since E. dispar is ten-times more prevalent than E. histolytica, the inability to differentiate between both protozoa may lead to unnecessary treatments. However, there is some experimental evidence that demonstrates that E. dispar can become pathogenic in cer­tain special situations. [42],[43],[44],[45] In addition, the la­boratory tests needed to correctly identify both protozoa are expensive to be applied routinely.

Another topic, often pursued by physicians diagnosing an intestinal parasite infection, is the presence of eosinophilia in the infected patients. [46] Eosinophilia was present in both groups, and the number of cases in each group was not significantly different (P > 0.05). The presence of eosinophilia could be attributed to the fact that all the HD patients had contact with several artificial substances, such as ca­theters and intravenous blood lines. It is also possible that manufactured products used in the dialysis process can promote an increase in the number of eosinophils in blood.

With respect to the patients' family income, the data show that the incomes in both the HD patient groups were not significantly different. The subjects in both groups also consumed filtered water, had a sewage network in their residence and consumed vegetables only after cleaning. Although the city of Uberlandia in Brazil is situated in a developing country, it has adequate service for the treatment of water and sewage, which may explain the absence of statistical differences in these variables.

Despite the fact that there was no statistical significance in the values, diarrhea occurred in 42.9% of the infected group versus 21.4% (NS) of the subjects in the control group. Certainly, the small number of individuals who represen­ted our sample of cases influenced the out­come of the performed statistical analyses. However, there was a tendency for more cases of diarrhea in the Eh/Ed-positive group com­pared with the controls. If this observation is confirmed in future studies that contain a lar­ger sample population, it will be possible to question whether E. dispar may or may not be pathogenic to people undergoing hemodialy­sis. The low-immune competence of these in­dividuals and the possibility of concurrent infections could contribute to this reasoning. HD patients who are positive for the Eh/Ed com­plex could be treated with the appropriate me­dication soon after a positive microscopic diag­nosis, as the risks and benefits analysis would favor the initiation of therapy.

The incidence of the Eh/Ed complex, which is transmitted through the ingestion of conta­minated food and water, is greater in areas with poor hygienic conditions and a low socio­-economic level. [28],[47] However, our data show that physicians should not solely rely upon socio-economic parameters for the diagnosis of intestinal amebiasis, especially in places with an adequate health structure, such as the city where this study was conducted. Factors other than those investigated in this study may be involved in the epidemiology of HD patients.

Limitations of the Study

The introduction of bias is a factor that should be considered, particularly the type of selec­tion process. For example, a sample population with a small number of patients who have si­milar characteristics could have influenced the determination of risk factors that were pre­viously cited in the literature in association with infection with E. histolytica/E. dispar. How­ever, the careful selection of our control group provided comparable features with the positive cases, as they were matched by sex, age and length of dialysis. Therefore, it is believed that this type of bias was not introduced into this study. However, the defect of memory, usually observed in retrospective studies, may have been introduced, and should be considered in the investigated clinical symptoms. For the study part related to the patients' residence, the surveyed factors were not as dependent on memories, which minimized this type of bias.

In conclusion, we suggest that a parasito­logical examination of the patient's stool to detect the Eh/Ed complex should be included with the routine tests so that those patients with a positive fecal test could be initiated on appropriate anti-Eh/Ed therapy.

 
   References Top

1.Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of ac­quired immunity in hemodialysis patients. Semin Dial 2007;20:440-51.  Back to cited text no. 1
[PUBMED]  [FULLTEXT]  
2.Vanholder R, De SR, Hsu C, Vogeleere P, Ringoir S. Uremic toxicity: the middle mole­cule hypothesis revisited. Semin Nephrol 1994; 14:205-18.  Back to cited text no. 2
    
3.Newberry WM, Sanford JP. Defective cellular immunity in renal failure: depression of reacti­vity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest 1971;50: 1262-71.  Back to cited text no. 3
[PUBMED]  [FULLTEXT]  
4.Schindler R, Linnenweber S, Schulze M, et al. Gene expression of interleukin-1 beta during hemodialysis. Kidney Int 1993;43:712-21.  Back to cited text no. 4
[PUBMED]    
5.Girndt M, Heisel O, Kohler H. Influence of dialysis with polyamide vs haemophan haemo­dialysers on monokines and complement acti­vation during a 4-month long-term study. Nephrol Dial Transplant 1999;14:676-82.  Back to cited text no. 5
    
6.Kaneko T, Osono E, Hayama N, Lino Y, Terashi A. T-cell activation modified by para­thyroid hormone (PTH) in patients with end­stage renal disease. Clin Nephrol 1997;48:353-­8.  Back to cited text no. 6
[PUBMED]    
7.Yang S, Smith C, Prahl JM, Luo X, DeLuca HF. Vitamin D deficiency suppresses cell­mediated immunity in vivo. Arch Biochem Biophys 1993;303:98-106.  Back to cited text no. 7
[PUBMED]    
8.Giacchino F, Belardi P, Coppo R, et al. Effects of blood transfusion on cellular immunity. Proc Eur Dial Transplant Assoc 1981;18:465­-8.  Back to cited text no. 8
[PUBMED]    
9.Hoen B, Kessler M, Hestin D, Mayeux D. Risk factors for bacterial infections in chronic hae­modialysis adult patients: A multicentre pros­pective survey. Nephrol Dial Transplant 1995; 10:377-81.  Back to cited text no. 9
[PUBMED]  [FULLTEXT]  
10.Stachowski J, Pollok M, Burrichter H, Spithaler C, Baldamus CA. Does uremic environment down-regulate T cell activation via TCR/CD3 antigen receptor complex? J Clin Lab Immunol 1991;36:15-21.  Back to cited text no. 10
[PUBMED]    
11.Stachowski J, Pollok M, Burrichter H, Bal­damus CA. Immunodeficiency in ESRD-pa­tients is linked to altered IL-2 receptor density on T cell subsets. J Clin Lab Immunol 1991; 34:171-7.  Back to cited text no. 11
    
12.Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000;58:1758-64.  Back to cited text no. 12
[PUBMED]  [FULLTEXT]  
13.Malik GH, Al-Harbi AS, Al-Mohaya S, et al. Eleven years of experience with dialysis asso­ciated tuberculosis. Clin Nephrol 2002;58:356­62.  Back to cited text no. 13
[PUBMED]    
14.Gordillo R, Kumar J, Del RM, Flynn JT, Woroniecki RP. Outcome of dialysis in chil­dren with human immunodeficiency virus in­fection. Pediatr Nephrol 2009;24:171-5.  Back to cited text no. 14
    
15.Ballester JM, Rivero RA, Villaescusa R, et al. Hepatitis C virus antibodies and other markers of blood-transfusion-transmitted infection in multi-transfused Cuban patients. J Clin Virol 2005;34(Suppl2):S39-46.  Back to cited text no. 15
    
16.Al-Dhahry SS, Aghanashinikar PN, Al-Mar­huby HA, Buhl MR, Daar AS, Al-Hasani MK. Hepatitis B, delta and human immunodefi­ciency virus infections among Omani patients with renal diseases: A seroprevalence study. Ann Saudi Med 1994;14:312-5.  Back to cited text no. 16
    
17.Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of hemodia­lysis associated diseases in the United States, 1990. ASAIO J 1993;39:71-80.  Back to cited text no. 17
[PUBMED]    
18.Marcus R, Favero MS, Banerjee S, et al. Pre­valence and incidence of human immunodefi­ciency virus among patients undergoing long­term hemodialysis. The Cooperative Dialysis Study Group. Am J Med 1991;90:614-9.  Back to cited text no. 18
[PUBMED]    
19.Alter MJ, Favero MS, Miller JK, Moyer LA, Bland LA. National surveillance of dialysis­associated diseases in the United States, 1987. ASAIO Trans 1989;35:820-31.  Back to cited text no. 19
[PUBMED]    
20.van Dijk PC, Jager KJ, de CF, et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001;16:1120-9.  Back to cited text no. 20
    
21.Seyrafian S, Pestehchian N, Kerdegari M, Yousefi HA, Bastani B. Prevalence rate of Cryptosporidium infection in hemodialysis patients in Iran. Hemodial Int 2006;10:375-9.  Back to cited text no. 21
[PUBMED]  [FULLTEXT]  
22.Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syn­drome). Nephrol Dial Transplant 2000;15:953­60.  Back to cited text no. 22
    
23.Kakiya R, Shoji T, Tsujimoto Y, et al. Body fat mass and lean mass as predictors of survi­val in hemodialysis patients. Kidney Int 2006;70:549-56.  Back to cited text no. 23
[PUBMED]  [FULLTEXT]  
24.Herselman M, Moosa MR, Kotze TJ, Kritzinger M, Wuister S, Mostert D. Protein-energy mal­nutrition as a risk factor for increased morbi­dity in long-term hemodialysis patients. J Ren Nutr 2000;10:7-15.  Back to cited text no. 24
[PUBMED]  [FULLTEXT]  
25.Yang YF, Wang HJ, Kan WC, Kuo HL, Huang CC. Pyogenic liver abscess in ESRD patients undergoing maintenance dialysis therapy. Am J Kidney Dis 2006;47:856-61.  Back to cited text no. 25
[PUBMED]  [FULLTEXT]  
26.Shamsuzzaman SM, Hashiguchi Y. Thoracic amebiasis. Clin Chest Med 2002;23:479-92.  Back to cited text no. 26
[PUBMED]    
27.Ohnishi K, Murata M, Kojima H, Takemura N, Tsuchida T, Tachibana H. Brain abscess due to infection with Entamoeba histolytica. Am J Trop Med Hyg 1994;51:180-2.  Back to cited text no. 27
[PUBMED]  [FULLTEXT]  
28.Petri WA Jr, Singh U. Diagnosis and manage­ment of amebiasis. Clin Infect Dis 1999;29: 1117-25.  Back to cited text no. 28
[PUBMED]  [FULLTEXT]  
29.Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the glob­al magnitude of morbidity and mortality. Rev Infect Dis 1986;8:228-38.  Back to cited text no. 29
[PUBMED]    
30.WHO - Weekly Epidemiological Report. 14. 1997. Geneva. Ref Type: Report  Back to cited text no. 30
    
31.Costa AO, Gomes MA, Rocha OA, Silva EF. Pathogenicity of Entamoeba dispar under xenic and monoxenic cultivation compared to a virulent E. histolytica. Rev Inst Med Trop Sao Paulo 2006;48:245-50.  Back to cited text no. 31
[PUBMED]  [FULLTEXT]  
32.Diamond LS, Clark CG. A redescription of En­tamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol 1993;40:340-4.  Back to cited text no. 32
[PUBMED]    
33.Vohra H, Bhatti HS, Ganguly NK, Mahajan RC. Virulence of pathogenic and non-patho­genic zymodemes of Entamoeba histolytica (Indian strains) in guinea-pigs. Trans R Soc Trop Med Hyg 1989;83:648-50.  Back to cited text no. 33
[PUBMED]    
34.Chadee K, Smith JM, Meerovitch E. Enta­moeba histolytica: electrophoretic isoenzyme patterns of strains and their virulence in the cecum of gerbils (Meriones unguiculatus). Am J Trop Med Hyg 1985;34:870-8.  Back to cited text no. 34
[PUBMED]  [FULLTEXT]  
35.Hammer J, Oesterreicher C, Hammer K, Koch U, Traindl O, Kovarik J. Chronic gastrointes­tinal symptoms in hemodialysis patients. Wien Klin Wochenschr 1998;110:287-91.  Back to cited text no. 35
[PUBMED]    
36.Hoffmann WA, Pons JA, Janer JL. The sedi­mentation concentrations method in schistoso­miasis mansoni. Puerto Rico J Pub Hlth Trop Med 1934;2:283-98.  Back to cited text no. 36
    
37.Lauritsen JM. EpiData Data Entry, Data Ma­nagement and basic Statistical Analysis System. 2000. Odense Denmark, EpiData Association. Ref Type: Computer Program.  Back to cited text no. 37
    
38.Lauritsen JM, Bruus M. EpiData Entry 3.1. A comprehensive tool for validated entry and documentation of data. (3.1). 2004. Odense Denmark, The EpiData Association. Ref Type: Computer Program  Back to cited text no. 38
    
39.Dean AG. Epi Info: A database and statistics program for public health professional. Versáo 3.3.2. 2005. Atlanta. Ref Type: Audiovisual Material.  Back to cited text no. 39
    
40.Ayres M, Ayres Jr M, Ayres DL, Santos AS. BioEstat 4.0 biological and medical statistical application, Brasília, CNPq, 2006:324-410  Back to cited text no. 40
    
41.Huston CD, Petri WA. Amebiasis: Clinical Im­plications of the Recognition of Entamoeba dispar. Curr Infect Dis Rep 1999;1:441-7.  Back to cited text no. 41
[PUBMED]    
42.Costa AO, Gomes MA, Rocha OA, Silva EF. Pathogenicity of Entamoeba dispar under xenic and monoxenic cultivation compared to a virulent E. histolytica. Rev Inst Med Trop Sao Paulo 2006;48:245-50.  Back to cited text no. 42
[PUBMED]  [FULLTEXT]  
43.Diamond LS, Clark CG. A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol 1993;40:340-4.  Back to cited text no. 43
[PUBMED]    
44.Vohra H, Bhatti HS, Ganguly NK, Mahajan RC. Virulence of pathogenic and non-patho­genic zymodemes of Entamoeba histolytica (Indian strains) in guinea-pigs. Trans R Soc Trop Med Hyg 1989;83:648-50.  Back to cited text no. 44
[PUBMED]    
45.Chadee K, Smith JM, Meerovitch E. Enta­moeba histolytica: electrophoretic isoenzyme patterns of strains and their virulence in the cecum of gerbils (Meriones unguiculatus). Am J Trop Med Hyg 1985;34:870-8.  Back to cited text no. 45
[PUBMED]  [FULLTEXT]  
46.Vanherweghem JL, Drukker W, Schwarz A. Clinical significance of blood-device interac­tion in hemodialysis. A review. Int J Artif Organs 1987;10:219-32.  Back to cited text no. 46
[PUBMED]    
47.Tanyuksel M, Yilmaz H, Ulukanligil M, et al. Comparison of two methods (microscopy and enzyme-linked immunosorbent assay) for the diagnosis of amebiasis. Exp Parasitol 2005;­110:322-6.  Back to cited text no. 47
[PUBMED]  [FULLTEXT]  

Top
Correspondence Address:
Sebastiáo Rodrigues Ferreira-Filho
Rua Paraíba 3055, Uberlandia
Brazil
Login to access the Email id


PMID: 21422620

Rights and Permissions


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2], [Table 3]

This article has been cited by
1 Investigation of intestinal parasites in dialysis patients
Karadag, G. and Tamer, G.S. and Dervisoglu, E.
Saudi Medical Journal. 2013; 34(7): 714-718
[Pubmed]



 

Top
   
 
 
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  
 


 
    Abstract
    Introduction
    Patients and Methods
    Statistical Analysis
    Results
    Discussion
    References
    Article Figures
    Article Tables
 

 Article Access Statistics
    Viewed5397    
    Printed75    
    Emailed0    
    PDF Downloaded534    
    Comments [Add]    
    Cited by others 1    

Recommend this journal